Systolic Ankle arteriaL Pressure and Transcutaneous oximetrY During a TURTLE Test in Athletes (SALTY-TURTLE)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03568201 |
|
Recruitment Status :
Recruiting
First Posted : June 26, 2018
Last Update Posted : August 14, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Iliac Kinking | Diagnostic Test: Transcutaneous oximetry | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 60 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | transcutaneous oximetry |
| Masking: | None (Open Label) |
| Primary Purpose: | Diagnostic |
| Official Title: | Application de l'oxymétrie Dynamique et Des Index de Pression Pour le Diagnostic Des Plicatures Iliaques du Sportif |
| Actual Study Start Date : | December 17, 2018 |
| Estimated Primary Completion Date : | April 16, 2021 |
| Estimated Study Completion Date : | April 16, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: patients
Patients suspected of iliac kinking will have a transcutaneous oximetry test during hip flexion
|
Diagnostic Test: Transcutaneous oximetry
Measurement of TcpO2 on calves and chests. Calculation of the DROP index (decrease from rest of oxygen pressure)on both calves. |
|
Sham Comparator: controls
Healthy asymptomatic athletes will have a transcutaneous oximetry test during hip flexion
|
Diagnostic Test: Transcutaneous oximetry
Measurement of TcpO2 on calves and chests. Calculation of the DROP index (decrease from rest of oxygen pressure)on both calves. |
- Presence of a significant DROP decrease [ Time Frame: 1 hour ]Comparison of DROP value between PES patients and controls
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Age over 18 years Insurance company affiliation Symptoms consistent with iliac kinking (patients) or absence of symptoms (controls)
Exclusion Criteria:
- Refuse to participate Exclusion period from another protocole Non affiliation to the French healthcare system
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03568201
| Contact: pierre Abraham, MD, PhD | +33241354093 | piabraham@chu-angers.fr |
| France | |
| Centre hospitalier universitaire | Recruiting |
| Angers, France, 49933 | |
| Contact: Pierre Abraham, MD, PhD | |
| Principal Investigator: Pierre Abraham, MD PhD | |
| Principal Investigator: | Pierre Abraham, MD, PhD | University hospital in Angers |
| Responsible Party: | University Hospital, Angers |
| ClinicalTrials.gov Identifier: | NCT03568201 |
| Other Study ID Numbers: |
2018 A01046/ 49 |
| First Posted: | June 26, 2018 Key Record Dates |
| Last Update Posted: | August 14, 2020 |
| Last Verified: | August 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Diagnosis Peripheral artery disease Sports |

